tirzepatide and glp 1 GLP-1 vs. GLP-1 + GIP: What's the Difference for your Metabolism? Decoding GLP-1 Weight Loss Medications

Long-term, high-dose use is more likely to cause these rare side effects

Research shows Mounjaro leads to an average weight loss of around 26% after one year

What Its Studied For FDA-approved tirzepatide has been studied in the SURMOUNT (weight management) and SURPASS (type 2 diabetes) trial programs and carries formal labeling for those uses

When HbA 1c was measured in %, tirzepatide at doses of 15 mg, 10 mg and 5 mg demonstrated greater efficacy than semaglutide at doses of 2.0 mg (MD = 0.38% [95% CI 0.75% to 0.01%]), 1.0 mg (MD = 0.45% [95% CI 0.60% to 0.31%]) and 0.5 mg (MD = 0.51% [95% CI 0.68% to 0.33%]), respectively (ESM Table 7)

Increased Appetite : Some women feel hungrier when they start taking birth control pills